Cost utility of drugs for multiple sclerosis. Methods used don't calculate true benefit.

Cost utility of drugs for multiple sclerosis. Methods used don't calculate true benefit.

Show other versions (1)

Detalhes bibliográficos
Main Authors:	Richards, R, Burls, A, Payne, N
Formato:	Journal article
Idioma:	English
Publicado em:	2000

Descrição
Resumo: